Motoyasu Miura
Overview
Explore the profile of Motoyasu Miura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakano Y, Miura M, Namiki N, Uchida S
Chem Pharm Bull (Tokyo)
. 2024 Nov;
72(11):936-943.
PMID: 39496399
Orally disintegrating tablets (ODTs) can be easily swallowed without drinking water and are a convenient dosage form for the elderly and infirmed patients, as well as other patients, such as...
2.
Miura M, Kojima S, Tanaka S, Kashiwagura Y, Namiki N, Uchida S
Int J Clin Pharmacol Ther
. 2024 May;
62(8):353-362.
PMID: 38699974
Objective: Visual analog scale (VAS) can be used to evaluate multiple parameters. There have been no reports on the verification of order effects or reproducibility of the VAS method for...
3.
Kawamoto S, Tanaka S, Miura M, Kashiwagura Y, Kamiya C, Hakamata A, et al.
Chem Pharm Bull (Tokyo)
. 2023 May;
71(6):441-446.
PMID: 37258198
Good adherence to medication is critical for successfully treating psychiatric disorders. Tailor-made pharmaceutical formulations can provide a suitable dosage form to meet the specific needs of individual patients who exhibit...
4.
Miura M, Tanaka S, Uchida S, Kamiya C, Katayama N, Hakamata A, et al.
Biol Pharm Bull
. 2021 Jun;
44(6):762-770.
PMID: 34078808
A cocktail study is an in vivo evaluation method to assess multiple CYP activities via a single trial and single administration of a cocktail drug that is a combination of...
5.
Miura M, Uchida S, Tanaka S, Kamiya C, Katayama N, Hakamata A, et al.
Xenobiotica
. 2021 Jan;
51(4):404-412.
PMID: 33393430
A cocktail approach is a method to comprehensively evaluate the activity of cytochrome P450 enzymes (CYPs) by co-administering multiple CYP substrates. This is the first report that compares the results...
6.
Miura M, Uchida S, Tanaka S, Inui N, Kawakami J, Watanabe H, et al.
Biol Pharm Bull
. 2019 Sep;
42(9):1590-1595.
PMID: 31474719
There are large inter- and intra-individual variations in CYP3A4 activity. Midazolam, which is predominantly metabolized to 1'-hydroxymidazolam and 4-hydroxymidazolam by CYP3A4, is considered an effective probe for CYP3A4. To determine...